SunSmart America: Evaluating a School-based Curriculum

SunSmart America:评估校本课程

基本信息

项目摘要

DESCRIPTION (provided by applicant): The aims of this study are (1) to evaluate the knowledge, attitudes and behaviors relating to skin cancer protective measures among elementary school students who participate in a skin cancer education curriculum, and (2) to examine correlates between knowledge, attitudes and behaviors, and between student and parental demographic characteristics, to identify factors that will increase sun protective behaviors. The study will be conducted in elementary schools (grades 3-5) in Palm Beach County, Florida. Two groups of schools (study group and control group) will be compared using pre and post-test measures. Students will be studied over a period of three years to assess the effectiveness of one year vs. multiple year interventions. Parental knowledge of skin cancer related issues will also be assessed and used as a covariate because parental knowledge is likely to be a predictor of student knowledge and/or behaviors. The SunSmart America curriculum will be used in the classrooms. It was adapted from the Australian SunSmart program by the Richard David Kann Melanoma Foundation. The Foundation will be the subcontractor on this grant, and will be responsible for teacher training and for implementing the curriculum. A multi-disciplinary faculty team at the University of Miami will be responsible for the evaluation components. The incidence of skin cancer, the most common type of cancer in the United States, is increasing at a faster rate than for any other cancer. Ultraviolet radiation (UVR) exposure from the sun is the main risk factor. Since more than half of a person's lifetime UVR exposure occurs during before age 18, children are a prime population for efforts to reduce UVR exposure, and schools provide an important venue to teach and model behaviors. Understanding factors related to sun protective behaviors will provide critical information needed to reduce the future burden of skin cancer. Thus it may be possible by increasing awareness of the dangers of UVR exposure, and altering school and recreational policies towards UVR, to change attitudes and behaviors. The study will also identify positive correlates between student and parental demographic characteristics and to determine factors that will improve chances of the use of sun protective behaviors. The results will be used for planning to implement the SunSmart America curriculum throughout Florida and nationwide.
描述(申请人提供):本研究的目的是:(1)评估参加皮肤癌教育课程的小学生对皮肤癌预防措施的知识、态度和行为,(2)检查知识、态度和行为之间的相关性,以及学生和父母人口统计学特征之间的相关性,找出增加防晒行为的因素。 该研究将在佛罗里达州棕榈海滩县的小学(3-5年级)进行。 两组学校(研究组和对照组)将使用测试前和测试后的措施进行比较。 学生将在三年内进行研究,以评估一年与多年干预措施的有效性。 还将评估父母对皮肤癌相关问题的知识并将其用作协变量,因为父母的知识可能是学生知识和/或行为的预测因子。 SunSmart America课程将在教室中使用。 它改编自澳大利亚SunSmart计划由理查德大卫卡恩黑色素瘤基金会。 基金会将是这笔赠款的分包商,并将负责教师培训和实施课程。 迈阿密大学的一个多学科教师小组将负责评估部分。 皮肤癌是美国最常见的癌症类型,其发病率的增长速度比任何其他癌症都要快。 来自太阳的紫外线辐射(UVR)是主要的风险因素。 由于一个人一生中一半以上的UVR暴露发生在18岁之前,儿童是努力减少UVR暴露的主要人群,学校提供了一个重要的场所来教授和示范行为。 了解与防晒行为相关的因素将为减少未来皮肤癌负担提供关键信息。 因此,通过提高人们对紫外线辐射危害的认识,改变学校和娱乐场所对紫外线辐射的政策,可以改变人们的态度和行为。 该研究还将确定学生和家长人口统计学特征之间的正相关性,并确定提高防晒行为使用机会的因素。 调查结果将用于规划在整个佛罗里达和全国范围内实施SunSmart America课程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert Scott Kirsner其他文献

Robert Scott Kirsner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert Scott Kirsner', 18)}}的其他基金

Developing strategies for effective debridement in patients for venous leg ulcers
制定对腿部静脉溃疡患者进行有效清创的策略
  • 批准号:
    10311083
  • 财政年份:
    2018
  • 资助金额:
    $ 30.18万
  • 项目类别:
University of Miami Clinical Research Unit of the Diabetic Foot Consortium
迈阿密大学糖尿病足联盟临床研究单位
  • 批准号:
    10214223
  • 财政年份:
    2018
  • 资助金额:
    $ 30.18万
  • 项目类别:
Developing strategies for effective debridement in patients for venous leg ulcers
制定对腿部静脉溃疡患者进行有效清创的策略
  • 批准号:
    10531195
  • 财政年份:
    2018
  • 资助金额:
    $ 30.18万
  • 项目类别:
Developing strategies for effective debridement in patients for venous leg ulcers
制定对腿部静脉溃疡患者进行有效清创的策略
  • 批准号:
    9772256
  • 财政年份:
    2018
  • 资助金额:
    $ 30.18万
  • 项目类别:
SunSmart America: Evaluating a School-based Curriculum
SunSmart America:评估校本课程
  • 批准号:
    7498375
  • 财政年份:
    2004
  • 资助金额:
    $ 30.18万
  • 项目类别:
SunSmart America: Evaluating a School-based Curriculum
SunSmart America:评估校本课程
  • 批准号:
    7122878
  • 财政年份:
    2004
  • 资助金额:
    $ 30.18万
  • 项目类别:
SunSmart America: Evaluating a School-based Curriculum
SunSmart America:评估校本课程
  • 批准号:
    6816268
  • 财政年份:
    2004
  • 资助金额:
    $ 30.18万
  • 项目类别:
SunSmart America: Evaluating a School-based Curriculum
SunSmart America:评估校本课程
  • 批准号:
    7292691
  • 财政年份:
    2004
  • 资助金额:
    $ 30.18万
  • 项目类别:

相似海外基金

CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
  • 批准号:
    10425188
  • 财政年份:
    2021
  • 资助金额:
    $ 30.18万
  • 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
  • 批准号:
    10683047
  • 财政年份:
    2021
  • 资助金额:
    $ 30.18万
  • 项目类别:
CONTRACT TITLE - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
合同名称 - 癌症预防剂开发计划:早期临床研究
  • 批准号:
    10223848
  • 财政年份:
    2020
  • 资助金额:
    $ 30.18万
  • 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
  • 批准号:
    10452466
  • 财政年份:
    2019
  • 资助金额:
    $ 30.18万
  • 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
  • 批准号:
    10894578
  • 财政年份:
    2019
  • 资助金额:
    $ 30.18万
  • 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
  • 批准号:
    10425187
  • 财政年份:
    2019
  • 资助金额:
    $ 30.18万
  • 项目类别:
CONTRACT TITLE - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
合同名称 - 癌症预防剂开发计划:早期临床研究
  • 批准号:
    10045660
  • 财政年份:
    2019
  • 资助金额:
    $ 30.18万
  • 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
  • 批准号:
    10691840
  • 财政年份:
    2019
  • 资助金额:
    $ 30.18万
  • 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
  • 批准号:
    10045662
  • 财政年份:
    2019
  • 资助金额:
    $ 30.18万
  • 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
  • 批准号:
    10045663
  • 财政年份:
    2019
  • 资助金额:
    $ 30.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了